Venova Medical, Inc. is a privately held company addressing the challenges associated with providing optimal vascular access for patients needing hemodialysis. The company has developed the Velocity System, a next generation percutaneous AVF technology designed to reduce the need for reinterventions to achieve fistula maturation and improve vascular access outcomes while reducing costs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/05/24 | $30,000,000 | Series B |
Aphelion Capital Cadence Healthcare Ventures Catalyst Health Ventures KOFA Healthcare Mirae Asset Capital ShangBay Capital | undisclosed |
